Clinical trial Recruiting at 1 site Interventional Ages 18 and up

AI-supported sleep program for people with mild cognitive impairment or dementia

Official title: A Behavioural Sleep Intervention Enabled by a Virtual Coach for People With Mild Cognitive Impairment and Mild Dementia: A Proof-of-concept Study

Run by The Hong Kong Polytechnic University · NCT07784946 · Data updated 2026-11-12

A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Kowloon, Hung Hom)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07784946 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with mild cognitive impairment or dementia who report sleep problems at least three nights per week and can provide informed consent.

Probably not a fit

Individuals with primary sleep disorders, severe chronic illnesses, or ongoing treatment for sleep disturbances may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized controlled trial compares an AI-supported behavioral sleep intervention to usual care in adults with mild cognitive impairment or mild dementia. Participants must have a GDS score of 4 or lower, report sleep problems at least three nights per week, and be reachable by phone. The study aims to determine feasibility, safety, and preliminary effects on sleep quality and related outcomes. Enrollment is limited to individuals at The Hong Kong Polytechnic University, with follow-up conducted through standard study contacts. Exclusion criteria include diagnosed primary sleep disorders, severe chronic illnesses likely to affect sleep, ongoing sleep or mood disorder treatments, and significant sensory impairments.

Why it matters

Potential benefit: If successful, the intervention could improve sleep quality and daily functioning for people with cognitive impairment.

How similar studies have gone: Previous studies in behavioral sleep interventions for cognitive-impaired populations have shown promise, though AI-supported approaches in this exact population are exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of mild cognitive impairment or dementia with the global deterioration scale (GDS) score at 4 or lower; endorse one or more sleep problems; experience sleep issues an average of 3 or more nights per week over the past month; reachable by phone; ability to provide informed consent and willingness to participate in the study.

Exclusion Criteria:

* have a prior diagnosis of a primary sleep disorder (e.g., sleep apnoea); have a severe chronic illness that may cause sleep problems (e.g., emphysema); currently receiving medical, psychological, or psychiatric treatment for sleep disturbance or depression; severe visual or hearing impairment; uncontrolled medical conditions that may interfere with participation.

Where it's running

  • The Hong Kong Polytechnic University
    Kowloon, Hung Hom, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.